WDR5 is a principal component of the H3K4me3 writer complex MLL–SET1 and interacts with MYC oncoprotein, allowing MYC to select its target genes and alter their expression epigenetically in cancer (Thomas et al., 2015). Here, KMT2A is linked to cancer.